Empagliflozin in adults hospitalised with COVID-19: a (null) hypothesis for RECOVERY [0.03%]
瑞维素在成人COVID-19住院患者中的疗效的(无效)假设——RECOVERY试验
Monia Garofolo,Giuseppe Penno
Monia Garofolo
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
Faster and faster: meeting the challenges of delayed insulin action during pregnancy [0.03%]
越变越快：妊娠期胰岛素作用延时的应对挑战
Denice S Feig
Denice S Feig
Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial [0.03%]
德谷胰岛素与门冬胰岛素治疗妊娠期及产后1型或2型糖尿病的疗效和安全性：一项开放性、单中心随机对照试验（CopenFast）
Sidse K Nørgaard,Julie C Søholm,Elisabeth R Mathiesen et al.
Sidse K Nørgaard et al.
Background: Faster-acting insulin aspart (faster aspart) is considered safe for use during pregnancy and breastfeeding but has not been evaluated in this population. We aimed to evaluate the effect of faster aspart versus...
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2023 Nov;11(11):811-821. DOI:10.1016/S2213-8587(23)00236-X 2023
The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries [0.03%]
低收入和中等收入国家心血管元性疾病预防、诊断及治疗的精准医疗案例分析
Shivani Misra,Carlos A Aguilar-Salinas,Tinashe Chikowore et al.
Shivani Misra et al.
Cardiometabolic diseases are the leading preventable causes of death in most geographies. The causes, clinical presentations, and pathogenesis of cardiometabolic diseases vary greatly worldwide, as do the resources and strategies needed to ...
Precision medicine for cardiometabolic disease: a framework for clinical translation [0.03%]
精准医学在心血管代谢性疾病中的临床应用框架
Paul W Franks,William T Cefalu,John Dennis et al.
Paul W Franks et al.
Cardiometabolic disease is a major threat to global health. Precision medicine has great potential to help to reduce the burden of this common and complex disease cluster, and to enhance contemporary evidence-based medicine. Its key pillars...
Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes [0.03%]
理解糖尿病的异质性：迈向精准医疗的关键步骤
Richard David Leslie,Ronald Ching Wan Ma,Paul W Franks et al.
Richard David Leslie et al.
Diabetes is a highly heterogeneous condition; yet, it is diagnosed by measuring a single blood-borne metabolite, glucose, irrespective of aetiology. Although pragmatically helpful, disease classification can become complex and limit advance...
Precision medicine of obesity as an integral part of type 2 diabetes management - past, present, and future [0.03%]
精准肥胖医学作为2型糖尿病治疗的组成部分：过去、现在和未来展望
Lukasz Szczerbinski,Jose C Florez
Lukasz Szczerbinski
Obesity is a complex and heterogeneous condition that leads to various metabolic complications, including type 2 diabetes. Unfortunately, for some, treatment options to date for obesity are insufficient, with many people not reaching sustai...
Mark A Atkinson,Michael J Haller,Desmond A Schatz et al.
Mark A Atkinson et al.